Citeline Podcasts

1359 Episodes

1. Pharma R&D 2022 - Chapter 3 - Arrival: The 2022 Pipeline by Phase

   Published: 3/15/2022
2. Pharma R&D 2022 - Chapter 1 - Introduction

   Published: 3/15/2022
3. ‘What’s Hot’ In UK Consumer Health? With The Difference Collective’s Stuart Mayell

   Published: 3/14/2022
4. Scrip’s Five Must-Know Things – 14 March 2022

   Published: 3/14/2022
5. Pink Sheet Podcast: Accelerated Approval Reform, US FDA Patient Engagement, Drug Access and COVID-19

   Published: 3/11/2022
6. Device Week, 10 March 2022 –Femtech Attracts Investors; ZimVie Fails To Impress

   Published: 3/10/2022
7. How To Jump Aboard The New EU Innovative Health Initiative Train And Where It Is Heading

   Published: 3/7/2022
8. Scrip’s Five Must-Know Things – 7 March 2022

   Published: 3/7/2022
9. Device Week, 4 March 2022 - FDA Gets First Feedback On QMSR Draft Reg

   Published: 3/4/2022
10. Exploring The Spinal Cord Stimulation Devices Market

    Published: 3/4/2022
11. Oncology – PARP inhibitors

    Published: 3/4/2022
12. The Future Of EU Probiotics Regulation, With David Pineda Ereño

    Published: 2/28/2022
13. Scrip’s Five Must-Know Things – 28 February 2022

    Published: 2/28/2022
14. Pink Sheet Podcast: Lower US FDA EUA Approval Standard, New Vaccines’ Role, HHS Biosimilar Study

    Published: 2/25/2022
15. Afrigen Chief On mRNA Vaccine Candidate, IP Hoops, Market-Shaping Efforts

    Published: 2/25/2022
16. Device Week, Feb. 24, 2022 – CardioMEMS, G7 Data, And Investment Outlook

    Published: 2/24/2022
17. Lactocore CEO On Peptide-Based Drug Candidates For Anxiety, Obesity, Parkinson’s And More

    Published: 2/23/2022
18. Digital Health Roundup – IBM Watson Health’s Failure; New FDA Standards; Autonomous Robots

    Published: 2/22/2022
19. Scrip’s Five Must-Know Things – 21 February 2022

    Published: 2/21/2022
20. Pink Sheet Podcast: Califf Confirmed, Lessons From Sintilimab Adcom, Generic Industry Execs Meet

    Published: 2/18/2022